SAFETY
Clinical trials for SAFETY explained in plain language.
Never miss a new study
Get alerted when new SAFETY trials appear
Sign up with your email to follow new studies for SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug HY07121 aims to shrink advanced tumors in early trial
Disease control Recruiting nowThis study tests a new drug, HY07121, in 258 adults with advanced solid tumors that have not responded to standard treatments. The goal is to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants receive the drug by infusion, and researchers …
Matched conditions: SAFETY
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 01, 2026 13:31 UTC
-
New hope for hard-to-treat colorectal cancer: combo therapy targets stubborn tumors
Disease control Recruiting nowThis study tests whether adding the experimental drug AK104 to standard chemotherapy and either cetuximab or bevacizumab can shrink tumors in people with a specific type of advanced colorectal cancer (MSS type) that has not responded to initial treatment. About 40 adults aged 18-…
Matched conditions: SAFETY
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New injection for Graves' disease enters first human safety trial
Disease control Recruiting nowThis early-stage study tests a single injection of a new drug called GenSci098 in 24 adults with Graves' disease, a condition where the thyroid is overactive. The main goal is to check if the drug is safe and how well people tolerate it. Researchers will monitor participants for …
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Stem cells injected into spine: hope for paralysis?
Disease control Recruiting nowThis early-stage study tests a new treatment made from stem cells that can become nerve cells. The cells are injected into the spine of people who had a spinal cord injury 2 to 8 weeks earlier. The main goal is to see if the treatment is safe and tolerable, with a small group of …
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New pill aims to spark motivation in Parkinson's patients
Symptom relief Recruiting nowThis study tests an experimental drug called IRL757 in 75 people with Parkinson's disease who also have apathy (lack of interest or motivation). The main goal is to check if the drug is safe and tolerable over 12 weeks. Researchers will also see if it helps improve apathy symptom…
Matched conditions: SAFETY
Phase: PHASE1, PHASE2 • Sponsor: Integrative Research Laboratories AB • Aim: Symptom relief
Last updated Apr 30, 2026 15:48 UTC
-
New inhaled drug RCS-21 put to the test in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage study tests whether a single inhaled dose of RCS-21 is safe and tolerable in 24 healthy adults aged 18 to 64. Participants receive one dose and are closely monitored for side effects. The study does not aim to treat any disease, but to gather important safety inf…
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: RNATICS GmbH • Aim: Knowledge-focused
Last updated May 01, 2026 13:29 UTC
-
Is this common supplement safe for daily use? new study aims to find out
Knowledge-focused Recruiting nowThis study is checking the long-term safety of a supplement called palmitoylethanolamide (PEA) in 200 healthy adults aged 18 and older. Participants will take either PEA or a placebo every day for 12 months and have regular check-ups, blood tests, and safety assessments. The goal…
Matched conditions: SAFETY
Phase: PHASE2 • Sponsor: RDC Clinical Pty Ltd • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC
-
Global survey aims to make breathing support safer outside the ICU
Knowledge-focused Recruiting nowThis study surveys 400 doctors, nurses, and respiratory therapists worldwide to understand how non-invasive ventilation (breathing support via mask or helmet) is used outside intensive care units. The goal is to identify current practices, outcomes, and barriers to guide safer an…
Matched conditions: SAFETY
Sponsor: Dr. Ram Manohar Lohia Hospital • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC